Structure of 22902-86-9
*Storage:
*Shipping:
4.5
*For Research Use Only !
Change View
Size | Price | US Stock | Global Stock | In Stock |
100mg | łÇ§¶ÊÊ | Inquiry | Inquiry | |
250mg | łËʶÊÊ | Inquiry | Inquiry | |
1g | łËͶÊÊ | Inquiry | Inquiry | |
5g | łîǶÊÊ | Inquiry | Inquiry | |
25g | ł§óʶÊÊ | Inquiry | Inquiry |
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
łÇ§¶ÊÊ
łËʶÊÊ
łËͶÊÊ
łîǶÊÊ
ł§óʶÊÊ
In Stock
- +
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
CAS No. : | 22902-86-9 |
Formula : | C9H6ClF3O2 |
M.W : | 238.59 |
SMILES Code : | OC(=O)CC1=CC(=C(Cl)C=C1)C(F)(F)F |
MDL No. : | MFCD04116012 |
InChI Key : | AZBFOENSKLAYKT-UHFFFAOYSA-N |
Pubchem ID : | 3519882 |
GHS Pictogram: | ![]() |
Signal Word: | Warning |
Hazard Statements: | H302-H315-H319-H335 |
Precautionary Statements: | P261-P305+P351+P338 |
Num. heavy atoms | 15 |
Num. arom. heavy atoms | 6 |
Fraction Csp3 | 0.22 |
Num. rotatable bonds | 3 |
Num. H-bond acceptors | 5.0 |
Num. H-bond donors | 1.0 |
Molar Refractivity | 48.0 |
TPSA ? Topological Polar Surface Area: Calculated from | 37.3 Ų |
Log Po/w (iLOGP)? iLOGP: in-house physics-based method implemented from | 1.76 |
Log Po/w (XLOGP3)? XLOGP3: Atomistic and knowledge-based method calculated by | 2.9 |
Log Po/w (WLOGP)? WLOGP: Atomistic method implemented from | 4.14 |
Log Po/w (MLOGP)? MLOGP: Topological method implemented from | 3.25 |
Log Po/w (SILICOS-IT)? SILICOS-IT: Hybrid fragmental/topological method calculated by | 3.26 |
Consensus Log Po/w? Consensus Log Po/w: Average of all five predictions | 3.06 |
Log S (ESOL):? ESOL: Topological method implemented from | -3.24 |
Solubility | 0.136 mg/ml ; 0.00057 mol/l |
Class? Solubility class: Log S scale | Soluble |
Log S (Ali)? Ali: Topological method implemented from | -3.34 |
Solubility | 0.108 mg/ml ; 0.000453 mol/l |
Class? Solubility class: Log S scale | Soluble |
Log S (SILICOS-IT)? SILICOS-IT: Fragmental method calculated by | -3.69 |
Solubility | 0.0493 mg/ml ; 0.000207 mol/l |
Class? Solubility class: Log S scale | Soluble |
GI absorption? Gatrointestinal absorption: according to the white of the BOILED-Egg | High |
BBB permeant? BBB permeation: according to the yolk of the BOILED-Egg | Yes |
P-gp substrate? P-glycoprotein substrate: SVM model built on 1033 molecules (training set) | No |
CYP1A2 inhibitor? Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set) | Yes |
CYP2C19 inhibitor? Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set) | No |
CYP2C9 inhibitor? Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set) | No |
CYP2D6 inhibitor? Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set) | No |
CYP3A4 inhibitor? Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set) | No |
Log Kp (skin permeation)? Skin permeation: QSPR model implemented from | -5.7 cm/s |
Lipinski? Lipinski (Pfizer) filter: implemented from | 0.0 |
Ghose? Ghose filter: implemented from | None |
Veber? Veber (GSK) filter: implemented from | 0.0 |
Egan? Egan (Pharmacia) filter: implemented from | 0.0 |
Muegge? Muegge (Bayer) filter: implemented from | 0.0 |
Bioavailability Score? Abbott Bioavailability Score: Probability of F > 10% in rat | 0.56 |
PAINS? Pan Assay Interference Structures: implemented from | 0.0 alert |
Brenk? Structural Alert: implemented from | 0.0 alert: heavy_metal |
Leadlikeness? Leadlikeness: implemented from | No; 1 violation:MW<1.0 |
Synthetic accessibility? Synthetic accessibility score: from 1 (very easy) to 10 (very difficult) | 1.8 |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With hydrogenchloride; acetic acid; at 100℃; for 2h; | Carbon tetrabromide (3.48 g, 10.5 mmol) and triphenylphosphine (2.75 g, 10.5 mmol) were added to a solution of [4-chloro-3-(trifluoromethyl)phenyl]methanol (2.00 g, 9.59 mmol) in tetrahydrofuran (12 ml) under ice-cooling, and the mixture was stirred at room temperature for 1 hour. Hexane was added to the reaction mixture, and the insolubles were removed by filtration. The obtained filtrate was poured into water and, after the mixture was extracted with ethyl acetate, the organic layer was successively washed with water and saturated aqueous NaCl solution, and dried over anhydrous sodium sulfate. The residue obtained by evaporating the solvent under reduced pressure was purified by silica gel column chromatography (elution solvent: n-hexane/ethyl acetate=4/1-2/1) to obtain 4-(bromomethyl)-1-chloro-2-(trifluoromethyl)benzene. Potassium cyanide (687 mg, 10.5 mmol) was added to a mixed solution of the obtained 4-(bromomethyl)-1-chloro-2-(trifluoromethyl)benzene in ethanol-water (3:1, 20 ml), and the mixture was stirred at 60C for 2 hours. The reaction mixture was poured into water and, after the mixture was extracted with ethyl acetate, the organic layer was washed with saturated aqueous NaCl solution and dried over anhydrous sodium sulfate. The residue obtained by evaporating the solvent under reduced pressure was subjected to silica gel column chromatography (elution solvent: n-hexane/ethyl acetate=4/1-2/1) to obtain crude [4-chloro-3-(trifluoromethyl)phenyl]acetonitrile. Acetic acid (6 ml) and concentrated hydrochloric acid (6 ml) were added to the obtained crude product, and the mixture was stirred at 100C for 2 hours. After the temperature of the reaction mixture was returned to room temperature, the mixture was poured into water, and the mixture was extracted with ethyl acetate. The organic layer was successively washed with water and saturated aqueous NaCl solution, and dried over anhydrous sodium sulfate. The solvent was evaporated under reduced pressure to obtain crude [4-chloro-3-(trifluoromethyl)phenyl]acetic acid. Methanol (12 ml) and concentrated sulfuric acid (1.0 ml) were added to the obtained crude product, and the mixture was stirred at 50C for 1 hour. The temperature of the reaction mixture was returned to room temperature, and the solvent was evaporated under reduced pressure. After ethyl acetate was added thereto, the organic layer was successively washed with water, saturated aqueous sodium hydrogencarbonate solution and saturated aqueous NaCl solution, and dried over anhydrous sodium sulfate. The residue obtained by evaporating the solvent under reduced pressure was purified by silica gel column chromatography (elution solvent: n-hexane/ethyl acetate=10/1) to obtain methyl [4-chloro-3-(trifluoromethyl)phenyl]acetate (1.08 g, two steps total yield: 45%). 1H-NMR (400MHz, CDCl3) : delta 7.58 (1H, d, J = 2.0 Hz), 7.45 (1H, d, J = 8.0 Hz), 7.37 (1H, dd, J = 8.0, 2.0 Hz), 3.70 (3H, s), 3.64 (2H, s). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With sulfuric acid; at 50℃; for 1h; | Carbon tetrabromide (3.48 g, 10.5 mmol) and triphenylphosphine (2.75 g, 10.5 mmol) were added to a solution of [4-chloro-3-(trifluoromethyl)phenyl]methanol (2.00 g, 9.59 mmol) in tetrahydrofuran (12 ml) under ice-cooling, and the mixture was stirred at room temperature for 1 hour. Hexane was added to the reaction mixture, and the insolubles were removed by filtration. The obtained filtrate was poured into water and, after the mixture was extracted with ethyl acetate, the organic layer was successively washed with water and saturated aqueous NaCl solution, and dried over anhydrous sodium sulfate. The residue obtained by evaporating the solvent under reduced pressure was purified by silica gel column chromatography (elution solvent: n-hexane/ethyl acetate=4/1-2/1) to obtain 4-(bromomethyl)-1-chloro-2-(trifluoromethyl)benzene. Potassium cyanide (687 mg, 10.5 mmol) was added to a mixed solution of the obtained 4-(bromomethyl)-1-chloro-2-(trifluoromethyl)benzene in ethanol-water (3:1, 20 ml), and the mixture was stirred at 60C for 2 hours. The reaction mixture was poured into water and, after the mixture was extracted with ethyl acetate, the organic layer was washed with saturated aqueous NaCl solution and dried over anhydrous sodium sulfate. The residue obtained by evaporating the solvent under reduced pressure was subjected to silica gel column chromatography (elution solvent: n-hexane/ethyl acetate=4/1-2/1) to obtain crude [4-chloro-3-(trifluoromethyl)phenyl]acetonitrile. Acetic acid (6 ml) and concentrated hydrochloric acid (6 ml) were added to the obtained crude product, and the mixture was stirred at 100C for 2 hours. After the temperature of the reaction mixture was returned to room temperature, the mixture was poured into water, and the mixture was extracted with ethyl acetate. The organic layer was successively washed with water and saturated aqueous NaCl solution, and dried over anhydrous sodium sulfate. The solvent was evaporated under reduced pressure to obtain crude <strong>[22902-86-9][4-chloro-3-(trifluoromethyl)phenyl]acetic acid</strong>. Methanol (12 ml) and concentrated sulfuric acid (1.0 ml) were added to the obtained crude product, and the mixture was stirred at 50C for 1 hour. The temperature of the reaction mixture was returned to room temperature, and the solvent was evaporated under reduced pressure. After ethyl acetate was added thereto, the organic layer was successively washed with water, saturated aqueous sodium hydrogencarbonate solution and saturated aqueous NaCl solution, and dried over anhydrous sodium sulfate. The residue obtained by evaporating the solvent under reduced pressure was purified by silica gel column chromatography (elution solvent: n-hexane/ethyl acetate=10/1) to obtain methyl [4-chloro-3-(trifluoromethyl)phenyl]acetate (1.08 g, two steps total yield: 45%). 1H-NMR (400MHz, CDCl3) : delta 7.58 (1H, d, J = 2.0 Hz), 7.45 (1H, d, J = 8.0 Hz), 7.37 (1H, dd, J = 8.0, 2.0 Hz), 3.70 (3H, s), 3.64 (2H, s). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Acetic acid (6 ml) and concentrated hydrochloric acid (6 ml) were added to the obtained [4-chloro-3-(trifluoromethyl)phenyl]acetonitrile and the mixture was stirred at 100C for 2 hours. After the temperature of the reaction mixture was returned to room temperature, the mixture was poured into water and extracted with ethyl acetate. The organic layer was successively washed with water and a saturated aqueous NaCI solution and dried with anhydrous sodium sulfate. The solvent was removed under reduced pressure to give crude [4-chloro-3-(trifluoromethyl)phenyl]acetic acid. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With thionyl chloride; at 60℃; for 1h; | e. Acetic acid 2-5-[2-(4-chloro-3-trifluoromethyl-phenyl)-acetylamino]-1-oxo-1H-isoquinolin-2-yl-ethyl ester The solution of <strong>[22902-86-9]2-(4-chloro-3-(trifluoromethyl)phenyl)acetic acid</strong> (131 mg, 0.000548 mol) in thionyl chloride (5 mL) was stirred at 60 C. for 1 hour. Thionyl chloride was removed, and residue was dissolved in tetrahydrofuran (5 mL). 2-(5-Amino-1-oxoisoquinolin-2(1H)-yl)ethyl acetate (100.0 mg, 0.0003655 mol) and N,N-diisopropylethylamine (95.5 muL, 0.000548 mol) were added and the reaction mixture was stirred at room temperature for 1 hour. The volatiles were removed, the residue was dissolved in ethylacetate, washed with water, dilute HCl and brine, and purified by column. The product was obtained as a beige solid (65 mg). MS m/z=467.4 (M+1). 1H NMR (DMSO-d6) delta 10.11(s, 1 H), 8.08(d, J=8.0 Hz, 1 H), 7.90(s, 1 H), 7.84(d, J=7.0 Hz, 1 H), 7.75-7.65 (m, 2 H), 7.55-7.42(m, 2 H), 6.69(d, J=7.6 Hz, 1 H), 4.33(t, J=5.1 Hz, 2 H), 4.20(t, J=5.1 Hz, 2 H), 3.92(s, 2 H), 1.96(s, 3 H). | |
In dichloromethane; at 0℃; for 1h;Inert atmosphere; | Oxalyl chloride (133 mg; 1.05 mmol) was added to a solution of 4-chloro-3- (trifluoromethyl)phenylacetic acid (50 mg; 0.21 mmol) and DMF (0.005 mL) in DCM (6 mL) at 0C under inert atmosphere and the resulting mixture was stirred at 0C for 1 hour. It was concentrated in vacuo and the residue was taken up in DCM (6 mL). N,N-diisopropylethylamine (72.23 mu; 0.42 mmol) |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
c. 2-(4-Chloro-3-(trifluoromethyl)phenyl)-N-(2-(1,3-dihydroxypropan-2-yl)-1-oxo-1, 2-dihydroisoquinolin-5-yl)acetamide To a solution of 5-amino-2-(1,3-dihydroxypropan-2-yl)isoquinolin-1(2H)-one (100.0 mg, 0.0004055 mol) in N,N-dimethylformamide (8 mL, 0.1 mol) was added <strong>[22902-86-9]2-(4-chloro-3-(trifluoromethyl)phenyl)acetic acid</strong> (378.0 mg, 0.001584 mol), N,N,N',N'-tetramethyl-O-(7-azabenzotriazol-1-yl)uronium hexafluorophosphate (448.0 mg, 0.001178 mol) and N,N-diisopropylethylamine (600.0 muL, 0.003445 mol). The reaction mixture was stirred for 16 hours at 50 C. After most of the DMF was rotovaped, MeOH (20 mL) and 2N NaOH (5 mL) were added to the residue. The solution was stirred for 1 hour at room temperature. MeOH was rotovaped and EtOAc (100 mL) was added, and the resultant solution was then washed with water (2*100 mL), Sat. NaHCO3, H2O, and brine. The EtOAc layer was dried by MgSO4 and was rotovaped. The resultant solution was washed with DCM and then purified with silica-gel. The final productproduct was obtained as a solid. MS m/z=455.1 (M+1). 1H NMR (400 MHz; DMSO-d6) delta 10.09(s, 1 H), 8.09(d, J=8.0 Hz, 1 H), 7.89(s, 1 H), 7.80(d, J=7.6 Hz, 1 H), 7.75-7.65(m, 2 H), 7.55-7.40(m, 2 H), 6.63(d, J=7.6 Hz, 1 H), 4.98-4.85(m, 3 H), 3.92(s, 2 H), 3.85-3.65 (m, 4 H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With N-ethyl-N,N-diisopropylamine; HATU; In N,N-dimethyl-formamide; at 20℃; for 16h; | c. (R)-2-(5-(2-(4-Chloro-3-(trifluoromethyl)phenyl)acetamido)-1-oxoisoquinolin-2(1H) -yl)propanamide A round bottom flask was charged with <strong>[22902-86-9]2-(4-chloro-3-(trifluoromethyl)phenyl)acetic acid</strong> (0.13 g, 0.00056 mol), N,N,N',N'-tetramethyl-O-(7-azabenzotriazol-1-yl)uronium hexafluorophosphate (0.3 g, 0.0009 mol), N,N-diisopropylethylamine (0.2 mL, 0.0009 mol), N,N-dimethylformamide (3 mL, 0.04 mol) and (R)-2-(5-amino-1-oxoisoquinolin-2(1H)-yl)propanamide (0.1 g, 0.0004 mol). The reaction was stirred at room temperature for 16 h. The solvent was removed under reduced pressure and the residue purified by flash chromatography (12 g, 0-10% MeOH/DCM) to get the product as white solid. MS m/z=451.8(M+H). 1H NMR (400 MHz; DMSO-d6) delta 10.10 (s, 1H), 8.07(d, J=8.42 Hz, 1H), 7.89 (s, 1H), 7.82 (d, J=8.47 Hz, 1H) 7.73-7.68 (m, 2H), 7.63 (s, 1H), 7.46 (d, J=7.57 Hz, 2H), 7.23 (bs, 1H), 6.68 (d, J=8.02 Hz, 1H), 5.50-5.45 (q, J=7.24 Hz, 1H), 3.92 (s, 2H), 1.54 (d, J=7.66 Hz, 3H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With N-ethyl-N,N-diisopropylamine; HATU; In N,N-dimethyl-formamide; at 20℃; for 16h; | c. N-(2-(2-Amino-2-oxoethyl)-1-oxo-1,2-dihydroisoquinolin-5-yl)-2-(4-chloro-3-(trifluoromethyl)phenyl)acetamide A round bottom flask was charged with <strong>[22902-86-9]2-(4-chloro-3-(trifluoromethyl)phenyl)acetic acid</strong> (170 mg, 0.00072 mol), N,N,N',N'-tetramethyl-O-(7-azabenzotriazol-1-yl)uronium hexafluorophosphate (400 mg, 0.001 mol), N,N-diisopropylethylamine (0.2 mL, 0.001 mol), N,N-dimethylformamide (2 mL, 0.03 mol) and 2-(5-amino-1-oxoisoquinolin-2(1H)-yl)acetamide (120 mg, 0.00055 mol). The reaction was stirred for 16 h at room temperature and the solvent was removed and the residue purified by preparative HPLC (reverse phase) to yield the product as a white powder. MS m/z=437.8 (M+1). 1H NMR (400 MHz; DMSO-d6) delta 10.09 (s, 1H), 8.04 (d, J=8.07 Hz, 1H), 7.89 (bs, 1H), 7.83 (d, J=8.07 Hz, 1H), 7.73-7.70 (m, 2H), 7.63 (bs, 1H), 7.46 (t, J=8.0 Hz, 1H), 7.42 (d, J=7.76 Hz, 1H) 7.19 (bs, 1H), 6.64 (d, J=7.70 Hz, 1H), 4.56 (s, 2H), 3.92 (s, 2H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With N-ethyl-N,N-diisopropylamine; HATU; at 20℃; for 16h; | c. (S)-2-5-[2-(4-Chloro-3-trifluoromethyl-phenyl)-acetylamino]-1-oxo-1 H-isoquinolin-2-yl-3-hydroxy-propionamide A round bottom flask was charged with <strong>[22902-86-9]2-(4-chloro-3-(trifluoromethyl)phenyl)acetic acid</strong> (0.12 g, 0.00052 mol), N,N,N',N'-tetramethyl-O-(7-azabenzotriazol-1-yl)uronium hexafluorophosphate (0.3 g, 0.0008 mol), N,N-diisopropylethylamine (0.1 mL, 0.0008 mol) and(S)-2-(5-amino-1-oxoisoquinolin-2(1H)-yl)-3-hydroxypropanamide (0.1 g, 0.0004 mol). The reaction was stirred for 16 h at room temperature and the solvent was removed and the residue purified by preparative HPLC (reverse phase) to yield the product as a white powder. MS m/z=468.3(M+H). 1H NMR (400 MHz; DMSO-d6) delta10.09 (s, 1H), 8.07 (d, J=8.34 Hz, 1H), 7.89 (bs, 1H), 7.81 (d, J=7.78 Hz, 1H), 7.73-7.66 (m, 3H), 7.53 (d, J=8.21 Hz, 1H), 7.44 (t, J=7.88 Hz, 1H), 7.30 (bs, 1H), 6.64 (d, J=7.88 Hz, 1H), 5.50 (t, J=6.69 Hz, 1H), 5.16 (t, J=5.48 Hz, 1H), 3.98-3.96 (m, 2H), 3.92 (s, 2H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With N-ethyl-N,N-diisopropylamine; HATU; In N,N-dimethyl-formamide; at 50℃; for 16h; | c. 2-(4-Chloro-3-(trifluoromethyl)phenyl)-N-(1-oxo-2-(piperidin-4-ylmethyl)-1, 2-dihydroisoquinolin-5-yl)acetamide hydrochloride To a solution of tert-butyl 4-((5-amino-1-oxoisoquinolin-2(1H)-yl)methyl)piperidine-1-carboxylate (100.0 mg, 0.0002658 mol) in N,N-dimethylformamide (5 mL, 0.06 mol) were added <strong>[22902-86-9]2-(4-chloro-3-(trifluoromethyl)phenyl)acetic acid</strong> (143.0 mg, 0.0005994 mol), N,N,N',N'-tetramethyl-O-(7-azabenzotriazol-1-yl)uronium hexafluorophosphate (360.0 mg, 0.0009468 mol) and N,N-diisopropylethylamine (305.0 muL, 0.001751 mol). The reaction mixture was stirred for 16 hours at 50 C. LC/MS was checked and the reaction was complete. EtOAc (100 mL) was added and the mixture was washed with water (2*100 mL), Sat. NaHCO3, H2O, and brine. The EtOAc layer was dried by MgSO4 and was rotovaped. The yellow residue was purified by silica-gel column, and a pure Boc protected product was obtained. To a solution of the Boc-protected product in 2 mL of dioxane was added 2M HCl in EtOEt (15 mL). The mixture was then stirred for 2 hours at room temperature to yield the final compound as a light colored solid (65.3 mg). MS m/z=478.2 (M+1). 1H NMR (400 MHz; DMSO-d6) delta 10.25(s, 1 H), 8.83(s, 1 H), 8.08(d, J=7.5 Hz, 1 H), 7.91(s, 1 H), 7.82(d, J=6.9 Hz, 1 H), 7.72(bs, 2 H), 7.55-7.40(m, 2 H), 6.71(d, J=6.8 Hz, 1 H), 4.20-3.80(m, 4 H), 3.28-3.15(m, 2 H), 2.90-2.70(m, 2 H), 2.10(bs 1 H), 1.80-1.60(m, 2 H), 1.52-1.35(m, 2 H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With N-ethyl-N,N-diisopropylamine; HATU; In N,N-dimethyl-formamide; at 50℃; for 16h; | c. N-(2-(3-Amino-2-(chloromethyl)propyl)-1-oxo-1,2-dihydroisoquinolin-5-yl)-2-(4-chloro-3-(trifluoromethyl)phenyl)acetamide To a solution of 3-(5-amino-1-oxo-1H-isoquinolin-2-ylmethyl)-azetidine-1-carboxylic acid-tert-butyl ester (96.0 mg, 0.000277 mol) in N,N-dimethylformamide (5 mL, 0.06 mol) is added <strong>[22902-86-9]2-(4-chloro-3-(trifluoromethyl)phenyl)acetic acid</strong> (150.0 mg, 0.0006287 mol), N,N,N',N'-tetramethyl-O-(7-azabenzotriazol-1-yl)uronium hexafluorophosphate (230.0 mg, 0.0006049 mol) and N,N-diisopropylethylamine (215 muL, 0.00123 mol). The reaction mixture was stirred for 16 hours at 50 C. LC/MS was checked, and the reaction was found to be complete. EtOAc (100 mL) was added, and the mixture was washed with water (2*100 mL), Sat. NaHCO3, H2O, and brine. The EtOAc layer was dried with MgSO4 and was rotovaped. The yellow residue was purified by silica-gel column to yield the pure Boc protected product. To a solution of the Boc-protected product in 2 mL dioxane was added 2M HCl in EtOEt (15 mL) and stirred for 2 hours at room temperature to obtain the title product which was purified by HPLC. MS m/z=487.2 (M+l). 1H NMR (400 MHz; DMSO-d6) delta 10.15(s, 1 H), 8.08(d, J=8.0 Hz, 1 H), 7.90(s, 1 H), 7.84(d, J=7.5 Hz, 1 H), 7.75-7.65(m, 2 H), 7.55-7.42(m, 2 H), 6.73(d, J=7.6 Hz, 1 H), 5.30-4.30(bs, 2H), 4.08(dd, J=13.4, 7.3 Hz, 1 H), 3.97(dd, J=13.5, 6.6 Hz, 1 H), 3.93(s, 2 H), 3.80(dd, J=11.2, 4.8 Hz, 1H), 3.73(dd, J=11.2, 5.1 Hz, 1 H), 2.67(d, J=6.0 Hz, 2 H), 2.45-2.30 (m, 1 H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With N-ethyl-N,N-diisopropylamine; HATU; In N,N-dimethyl-formamide; at 50℃; for 16h; | c. (S)-tert-Butyl 2-((5-(2-(4-chloro-3-(trifluoromethyl)phenyl)acetamido)-1-oxoisoquinolin-2(1H)-yl)methyl)pyrrolidine-1-carboxylate To a solution of (S)-tert-butyl 2-((5-amino-1-oxoisoquinolin-2(1H)-yl)methyl)pyrrolidine-1-carboxylate (248.0 mg, 0.0006860 mol) in N,N-dimethylformamide (10 mL, 0.1 mol) was added 2-(4-chloro-2-(trifluoromethyl)phenyl)acetic acid (350.0 mg, 0.001467 mol), N,N,N',N'-tetramethyl-O-(7-azabenzotriazol-1-yl)uronium hexafluorophosphate (530.0 mg, 0.001394 mol) and N,N-diisopropylethylamine (488.0 muL, 0.002802 mol). The reaction mixture was stirred for 16 hours at 50 C. LC/MS was checked, and revealed that the reaction was completed. EtOAc (100 ML) was added and the resulting solution was washed by water (2*100 mL), Sat. NaHCO3, H2O and brine. The EtOAc layer was dried with MgSO4 and was rotovaped. The yellow residue was purified by silica-gel column. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
32% | With 2,4,6-tripropyl-1,3,5,2,4,6-trioxatriphosphinane-2,4,6-trioxide; N-ethyl-N,N-diisopropylamine; In tetrahydrofuran; ethyl acetate; at 66℃; for 12h; | [00781] Example I[00782] N-[4-(4-amino-7,8-dihydro-6H-cyclopenta[2,3]pyrrolo[2,4-d]pyrim idin-5-yl)phenyl]-2- [4-chloro-3-(trifluoromethyl)phenyl]acetamide [00783] N,N-Diisopropylethylamine (131 pL, 0.7Smmol) was added to a stirred solution of 5-(4- aminophenyl)-7,8-dihydro-6H-cyclopenta[2,3]pyrrolo[2,4-d]pyrimidin-4-amine (100mg, 0.38mmol), propylphosphonic anhydride (50%, wt in EtOAc, 336jL, 0.S7mmol) and 2-[4-chloro-3- (trifluoromethyl)phenyl]acetic acid (89mg, 0.38mmol) in THF (3mL) and the solution was stirred at reflux for 12 hours. The solvent was removed in vacuo and the resulting residue was separated viaSCX eluting with 2M NH3 in methanol. The solvent was removed in vacuo and the resulting solid was purified via column chromatography using an eluent of 0-15% MeOH in DCM and then purified via preparative LCMS. The collected fractions were separated via SCX eluting with 2M NH3 in MeOH. The solvents were removed in vacuo, yielding an oil to which DCM (1 mL) and heptane (5mL) were added causing a solid to crash out which was filtered and dried to give N-[4-(4-amino-7,8-dihydro-6H-cyclopenta[2,3]pyrrolo[2,4-d]pyrimid in-5-yl)phenyl]-2-[4-chloro-3-(trifluoromethyl)phenyl]acetamide (58mg, 0.l2mmol, 32% yield) as a white powder.1H NMR (DMSO-d6, 400MHz) Olppm: 10.49 (1H, 5), 8.13 (1H, 5), 7.87-7.85 (1H, m), 7.65 (2H, d, J= 8.8Hz), 7.73-7.64 (2H, m), 7.39 (2H, d, J = 8.8Hz), 5.54 (2H, 5), 3.84 (2H, 5), 2.79 (2H, t, J =7.2Hz), 2.73 (2H, t, J = 7.2Hz), 2.47-2.40 (2H, m).MS Method 1: RT: 3.52mm, mlz 486.3 [M+H] |
Tags: 22902-86-9 synthesis path| 22902-86-9 SDS| 22902-86-9 COA| 22902-86-9 purity| 22902-86-9 application| 22902-86-9 NMR| 22902-86-9 COA| 22902-86-9 structure
A117253 [22893-39-6]
2-(2-Chloro-5-(trifluoromethyl)phenyl)acetic acid
Similarity: 0.90
A124150 [32857-62-8]
4-(Trifluoromethyl)phenylacetic acid
Similarity: 0.78
A301216 [351-35-9]
3-(Trifluoromethyl)phenylacetic acid
Similarity: 0.78
A470277 [1214352-00-7]
2-(3-Methyl-5-(trifluoromethyl)phenyl)acetic acid
Similarity: 0.78
A263483 [23228-45-7]
2-Chloro-4-(trifluoromethyl)benzoic acid
Similarity: 0.78
A117253 [22893-39-6]
2-(2-Chloro-5-(trifluoromethyl)phenyl)acetic acid
Similarity: 0.90
A124150 [32857-62-8]
4-(Trifluoromethyl)phenylacetic acid
Similarity: 0.78
A301216 [351-35-9]
3-(Trifluoromethyl)phenylacetic acid
Similarity: 0.78
A470277 [1214352-00-7]
2-(3-Methyl-5-(trifluoromethyl)phenyl)acetic acid
Similarity: 0.78
A263483 [23228-45-7]
2-Chloro-4-(trifluoromethyl)benzoic acid
Similarity: 0.78
A117253 [22893-39-6]
2-(2-Chloro-5-(trifluoromethyl)phenyl)acetic acid
Similarity: 0.90
A263483 [23228-45-7]
2-Chloro-4-(trifluoromethyl)benzoic acid
Similarity: 0.78
A169070 [53985-49-2]
3-Chloro-5-(trifluoromethyl)benzoic acid
Similarity: 0.78
A240897 [142994-09-0]
4-Chloro-2-(trifluoromethyl)benzoic acid
Similarity: 0.78
A103482 [34328-46-6]
4-Chloro-3-(trifluoromethyl)benzaldehyde
Similarity: 0.78
A117253 [22893-39-6]
2-(2-Chloro-5-(trifluoromethyl)phenyl)acetic acid
Similarity: 0.90
A124150 [32857-62-8]
4-(Trifluoromethyl)phenylacetic acid
Similarity: 0.78
A301216 [351-35-9]
3-(Trifluoromethyl)phenylacetic acid
Similarity: 0.78
A470277 [1214352-00-7]
2-(3-Methyl-5-(trifluoromethyl)phenyl)acetic acid
Similarity: 0.78
A263483 [23228-45-7]
2-Chloro-4-(trifluoromethyl)benzoic acid
Similarity: 0.78
A117253 [22893-39-6]
2-(2-Chloro-5-(trifluoromethyl)phenyl)acetic acid
Similarity: 0.90
A124150 [32857-62-8]
4-(Trifluoromethyl)phenylacetic acid
Similarity: 0.78
A301216 [351-35-9]
3-(Trifluoromethyl)phenylacetic acid
Similarity: 0.78
A470277 [1214352-00-7]
2-(3-Methyl-5-(trifluoromethyl)phenyl)acetic acid
Similarity: 0.78
A263483 [23228-45-7]
2-Chloro-4-(trifluoromethyl)benzoic acid
Similarity: 0.78
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :
Total Compounds: mg
The concentration of the dissolution solution you need to prepare is mg/mL